z-logo
open-access-imgOpen Access
Identifying Glucocorticoid Insufficiency in Silent Corticotroph Adenoma with Elevated Adrenocorticotropic Hormone
Author(s) -
Am Schlegel
Publication year - 2021
Publication title -
laboratory medicine
Language(s) - English
Resource type - Journals
eISSN - 1943-7730
pISSN - 0007-5027
DOI - 10.1093/labmed/lmab053
Subject(s) - corticotropic cell , adrenocorticotropic hormone , medicine , endocrinology , glucocorticoid , adrenal insufficiency , cortisol awakening response , hydrocortisone , basal (medicine) , context (archaeology) , metyrapone , pituitary gland , hormone , biology , paleontology , insulin
Silent corticotroph adenoma (SCA) is as an aggressive pituitary tumor. A 48 year old man developed hypogonadotrophic hypogonadism. The basal morning adrenocorticotropic hormone (ACTH) was elevated, but the basal morning and peak after ACTH (1–24) stimulation cortisol were normal. A 3.7 cm sellar mass with evidence of internal hemorrhage, encasement of the right internal carotid artery, and invasion of the right cavernous sinus were identified, resected, and stained positive for ACTH. Over the next 5 years, the basal morning ACTH and cortisol were normal, and imaging revealed the presence of a small residual tumor. One year later, the patient became fatigued and nauseated, with elevated ACTH. An overnight metyrapone stimulation test (OMST) revealed glucocorticoid insufficiency, without further increase in ACTH. Symptoms resolved with hydrocortisone treatment. This case study suggests that SCA can secrete an ACTH precursor that is detected by clinical assays but is not active biologically. Postoperative OMST reveals glucocorticoid insufficiency in this context.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom